Navigation Links
Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
Date:12/1/2008

PLYMOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ --Genaera Corporation (Nasdaq: GENR) today announced that dosing of subjects has begun in study MSI-1436C-102 (Study 102), the multiple ascending dose Phase 1b study of trodusquemine (MSI-1436) in overweight and obese type 2 diabetics. MSI-1436 is a novel therapeutic for the treatment of type 2 diabetes and obesity which works centrally and peripherally to regulate insulin and leptin pathways through the highly selective inhibition of its novel target enzyme, PTP-1B.

Study 102 will establish multiple dose pharmacokinetics (PK) and expand the safety database for MSI-1436 in a population of overweight and obese adult type 2 diabetic subjects who are poorly controlled on metformin. The study will also evaluate key secondary outcomes in this population, including oral glucose tolerance and insulin sensitivity, satiety and weight loss.

"We hope that Study 102 will help establish proof-of-concept for MSI-1436 as a highly competitive treatment for both type 2 diabetes and obesity with a single drug," said Jack Armstrong, President and Chief Executive Officer of Genaera. "In two previous Phase 1 studies, single doses of MSI-1436 administered to over 60 subjects were well-tolerated with an acceptable adverse event profile, exhibited linear PK, produced dose-dependent weight loss and improved insulin sensitivity. We expect the multiple dose data from Study 102 to verify the exciting potential and positive efficacy results of this drug."

Study 102 is a double-blind, randomized, placebo-controlled, safety and PK study being conducted at two U.S. sites. The study will initially enroll 21 subjects at three dose levels (3, 6, and 10 mg/m2) of MSI-1436 with treatment occurring every three days over a 23 day period. Five subjects in each dosing group will receive
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
3. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
11. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  The MEDevice San Diego Conference, ... an event dedicated to bringing medtech professionals together for ... topics affecting the industry today. This year,s conference will ... and opportunities facing today,s medtech professional in a fun, ... register for MEDevice San Diego, please visit: MEDeviceSD.com. ...
(Date:6/30/2015)... , June 30, 2015 Zynerba Pharmaceuticals, Inc. ... Form S-1 with the U.S. Securities and Exchange Commission (SEC) ... stock. The number of shares to be offered and the ... Jefferies LLC and Piper Jaffray & ... and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. will ...
(Date:6/30/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/54fkmt/global_array ... "Global Array Instruments Market 2015-2019" report to ... market to grow at a CAGR of 12.48 ... array instruments market can be divided into three ... tissue microarrays and cell microarrays. This report covers ...
Breaking Medicine Technology:MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
(Date:6/30/2015)... Detroit, MI (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable ... The 44-year-old native of Detroit, MI, Kid Rock, is hitting the road again this summer ... rock, country, and hip hop superstar kicked off his summer tour this year at the ...
(Date:6/30/2015)... ... ... a reliable source for last minute tickets for The Rolling Stones at Carter Finley ... in conjunction with their 2015 “Zip Code Tour.” , The Stones have been rocking for ... Some of the most beloved songs that this iconic group has performed over the ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to research by European archeologists that was ... three to four hundred thousand years ago likely knew that eating a balanced diet ... in fossilized, ancient dental plaque, researchers were able to find evidence of plant fibers, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Villa Health ... care centers in the country. To spread the word, Villa Health Care Center ... facility is, indeed, worthy of five stars. While Medicare centers its rating on ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... Trenton ... one of the first Medicaid Accountable Care Organizations (ACO) in the State, serving the ... July 1. , The Trenton Health Team ACO draws on the collaborative structure of ...
Breaking Medicine News(10 mins):Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 3Health News:Villa Health Care Center Announces Highest Care Rating in New Video 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3
... Donations needed for ... ... global health expert, Dr. Daniel Carucci, traveled to Haiti in the early morning to deliver ... to assess the situation on the ground to determine the best way to help the ...
... , , HARTFORD, Conn. , ... negotiated in the nation,s capital, but people struggling with the lack of ... when the National Association of Free Clinics (NAFC) holds its next C.A.R.E. ... will be the fifth in a series of large, mostly one-day C.A.R.E. ...
... , Troubled union still struggling to stop fair elections for thousands ... Jan. 15 After a year of stalling union elections ... officials have cast themselves as champions of democracy in a cynical move ... has blocked or delayed elections at more than 360 healthcare facilities in ...
... , , ... Lotus Pharmaceuticals, Inc.,(OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a ... pharmaceutical,products in the People,s Republic of China ("PRC"), today ... McLaughlin & Stern LLP. , The Company ...
... BOSTON , Jan. 15 Healthcare Data ... New England Quality Care Alliance (NEQCA), Tufts Medical Center Physicians ... use of their proprietary HDS Analyst(SM) tool. The contract was ... would meet the data monitoring needs of NEQCA and Tufts ...
... , PIEDMONT, Mo. , Jan. ... veterinary software, today announced a new veterinary web site ... creating and hosting web sites for veterinary clinics, PetWise ... access to their pet health information and medical records ...
Cached Medicine News:Health News:Update from Haiti: United Nations Foundation Vice President for Global Health Delivers Medical Supplies in Port-au-Prince 2Health News:Update from Haiti: United Nations Foundation Vice President for Global Health Delivers Medical Supplies in Port-au-Prince 3Health News:Free Health Care for the Uninsured Is Coming to Connecticut in February 2Health News:Free Health Care for the Uninsured Is Coming to Connecticut in February 3Health News:Latest Stunt at Labor Board Shows SEIU's Charges Have No Merit 2Health News:Latest Stunt at Labor Board Shows SEIU's Charges Have No Merit 3Health News:Lotus Pharmaceuticals Announces Key Changes 2Health News:Lotus Pharmaceuticals Announces Key Changes 3Health News:Healthcare Data Services (HDS) Announces Contract with the New England Quality Care Alliance (NEQCA), the Physicians Organization of Tufts Medical Center 2Health News:Healthcare Data Services (HDS) Announces Contract with the New England Quality Care Alliance (NEQCA), the Physicians Organization of Tufts Medical Center 3Health News:McAllister Software Announces PetWise Veterinary Web Site Design and Hosting Service 2Health News:McAllister Software Announces PetWise Veterinary Web Site Design and Hosting Service 3
... The Apollo Knee System has been ... through range of motion of any fixed ... area and low contact stress under loading ... contributes to long-term effectiveness. The universal symmetrical ...
The Advance revision knee system was designed to address the unpredictable nature of revision knee arthroplasty by providing a wide variety of implant and instrument options....
The AGC dual articular knee is indicated for severe primary or revision cases and features a patented unique articulation which allows controlled rotation of the femoral component about a central piv...
... NexGen CRA femoral component is intended ... anteroposterior, and varus/valgus ligament stability, yet ... to inadequate bone stock. The NexGen ... a PMMA precoat surface. This device ...
Medicine Products: